Assenagon Asset Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.8M | Buy |
631,622
+293,662
| +87% | +$14.3M | 0.05% | 271 |
|
|
2025
Q1 | $17.2M | Sell |
337,960
-101,710
| -23% | -$5.18M | 0.03% | 328 |
|
|
2024
Q4 | $19.8M | Sell |
439,670
-52,794
| -11% | -$2.38M | 0.03% | 338 |
|
|
2024
Q3 | $18.3M | Buy |
492,464
+119,637
| +32% | +$4.44M | 0.03% | 350 |
|
|
2024
Q2 | $11.4M | Buy |
372,827
+66,596
| +22% | +$2.04M | 0.03% | 386 |
|
|
2024
Q1 | $8.91M | Buy |
306,231
+63,570
| +26% | +$1.85M | 0.02% | 436 |
|
|
2023
Q4 | $6.69M | Buy |
242,661
+190,628
| +366% | +$5.25M | 0.02% | 528 |
|
|
2023
Q3 | $1.17M | Buy |
52,033
+46,247
| +799% | +$1.04M | ﹤0.01% | 982 |
|
|
2023
Q2 | $235K | Sell |
5,786
-13,291
| -70% | -$541K | ﹤0.01% | 1219 |
|
|
2023
Q1 | $924K | Sell |
19,077
-153,861
| -89% | -$7.45M | ﹤0.01% | 1039 |
|
|
2022
Q4 | $6.6M | Buy |
172,938
+43,716
| +34% | +$1.67M | 0.02% | 443 |
|
|
2022
Q3 | $6.49M | Buy |
129,222
+119,593
| +1,242% | +$6M | 0.02% | 407 |
|
|
2022
Q2 | $386K | Sell |
9,629
-101,279
| -91% | -$4.06M | ﹤0.01% | 1231 |
|
|
2022
Q1 | $4.14M | Buy |
110,908
+91,723
| +478% | +$3.42M | 0.01% | 552 |
|
|
2021
Q4 | $764K | Buy |
+19,185
| New | +$764K | ﹤0.01% | 1070 |
|
|
2021
Q2 | – | Sell |
-72,400
| Closed | -$3.43M | – | 1325 |
|
|
2021
Q1 | $3.43M | Hold |
72,400
| – | – | 0.01% | 561 |
|
|
2020
Q4 | $4.42M | Sell |
72,400
-194,900
| -73% | -$11.9M | 0.02% | 337 |
|
|
2020
Q3 | $12.5M | Buy |
+267,300
| New | +$12.5M | 0.07% | 139 |
|
|
2020
Q1 | – | Sell |
-102,737
| Closed | -$4.93M | – | 909 |
|
|
2019
Q4 | $4.93M | Buy |
+102,737
| New | +$4.93M | 0.03% | 209 |
|